Molecular Determinants of Virus-Sialic Acid Binding and its Role in Infection and Dissemination at distinct niches
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 522657
Grant search
Key facts
Disease
Disease XStart & end year
2025Known Financial Commitments (USD)
$941,999.32Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Maya ShmulevitzResearch Location
CanadaLead Research Institution
University of AlbertaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Viruses are tiny infectious agents that rely on specific sugars called sialic acids (Sias), found on the surface of cells, to attach and enter host cells, leading to infection. This research focuses on understanding how different viruses, particularly the mammalian orthoreovirus (MRV), interact with these sugars and how this affects the virus' ability to infect various tissues and spread throughout the body. Current knowledge is limited when it comes to the details of how variations in the virus's binding proteins influence its behavior. Our study explores this by analyzing a range of MRV mutants with different binding strengths to Sias. Exciting preliminary findings suggest that viruses with weaker attachment to cells might actually sometimes have an advantage over stronger binders, and sometimes a disadvantage, depending on where they need to infect and spread to. We aim to map out how these different MRV variants interact with Sias, investigate their movement through different environments. MRV is a safe virus being evaluated as a cancer therapy, and so by enhancing our understanding of viral behavior through this research, we hope to improve the design of MRV for therapeutic purposes, making them more effective for fighting diseases like cancer. At the same time, many disease causing viruses like influenza and the virus that causes COVID-19 also use Sias, so our findings will shed light on how mutations in such viruses could also affect their behaviours in different environments.